Skip to main content
Log in

Commentary on: Risk Factors for Abscess Development Following Percutaneous Microwave Ablation Therapy of Hepatic Tumors

  • Commentary
  • Interventional Oncology
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kwak DH, Yu Q, Malavia M, et al. Risk factors for abscess development following percutaneous microwave ablation therapy of hepatic tumors. Cardiovasc Intervent Radiol. 2022. https://doi.org/10.1007/s00270-022-03325-6.

    Article  PubMed  Google Scholar 

  2. Dollinger M, Beyer LP, Haimerl M, et al. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience. Diagn Interv Radiol. 2015;21:471–5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Devulopalli K, Fidelman N, Soulen M, et al. Safety of yttrium-90 radioembolization for patients with history of biliary tract instrumentation: final results of a multicenter study. J Vasc Interv Radiol. 2017;28:S164–5.

    Article  Google Scholar 

  4. Macomber MW, Schaub SK, Apisarnthanarax S. Case reports: liver abscess after hepatic stereotactic body radiation therapy. Pract Radiat Oncol. 2018;8:e255–8.

    Article  PubMed  Google Scholar 

  5. Kroner PT, Bilal M, Samuel R, et al. Use of ERCP in the United States over the past decade. Endosc Int Open. 2020;8:E761–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zlatko Devcic.

Ethics declarations

Conflict of interest

BT is an advisor to Boston Scientific Corporation, Sirtex, Johnson and Johnson, AstraZeneca, Genentech, Eisai, Histosonics, and Vivos. ZD has no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, informed consent is not required.

Consent for Publication

For this type of study, consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Devcic, Z., Toskich, B. Commentary on: Risk Factors for Abscess Development Following Percutaneous Microwave Ablation Therapy of Hepatic Tumors. Cardiovasc Intervent Radiol 46, 737–738 (2023). https://doi.org/10.1007/s00270-023-03438-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-023-03438-6

Navigation